Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label study of JMKX003142 versus torasemide in patients with renal edema
CTR20244341Phase 2Active
- Sponsor
- Zhejiang Hangyu Pharmaceutical
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JMKX003142 in edema, sponsored by Zhejiang Hangyu Pharmaceutical. Started Jan 2025; status: active.
02
Drugs
JMKX003142
03
Conditions
edema
Beyond the preview
Go deeper on CTR20244341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244341.